Antibiotic, Gingival-biopsy, and Oral-smear Samples.
NCT04172207 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45
Last updated 2019-11-26
Summary
Antimicrobial or antibiotic agents, which are essential to prevent and treat bacterial infectious diseases, have become one of the most widely used drugs in the world. In the European region, the highest rates of antibiotic consumption are reported in Turkey. There is a nearly fivefold difference between Turkey and the lowest consuming countries.
Studies in dentistry evaluate participants according to the basis of predefined criteria. History of antibiotic consumption is one of the most common exclusion criteria for periodontal trials. However, there is still disagreement on how long the effect of systemic antibiotic agents on the oral mucosa and periodontal tissue lasts. It is unclear whether the timing of antibiotic consumption should be an exclusion criterion for genetic damage and histological studies during the selection of healthy participants.
Periodontal status of participants in study groups is described as with or without periodontitis in many studies, because of the lack of clear definitions of periodontal health and gingivitis. It should be recognized that even the lack of visual signs of inflammation, some mild histopathological changes can be seen in the periodontium. Consequently, for the real diagnosis of the clinically healthy periodontium, clinical findings should be supported and confirmed with histological results.
Micronuclei (Mn) are observed as abnormal nuclear structures and indicators of chromosomal level DNA damage. The oral mucosa epithelium is an immunologic barrier and affected by chemical factors such as antibiotic consumption. The Mn test to exfoliated epithelial cells from the oral cavity is utilized as a non-invasive diagnostic technique for monitoring the status of oral health. To our knowledge, no studies have been conducted on the comparison of the impacts of the timing of antibiotic consumption on human periodontal tissues and oral smear samples. The present study is undertaken to determine whether the different timing of antibiotic (amoxicillin) therapy has effects on the histopathology of gingiva and genetic damage of exfoliated cells from oral mucosa in healthy participants.
Conditions
- Anti-bacterial Agents
- Chromosome-defective Micronuclei
- Cytology
- Histopathology
Interventions
- OTHER
-
Sampling
After periodontal parameters measured, smear samples were obtained from the buccal mucosa and keratinized gingiva, and then a gingival biopsy was performed from the upper premolars.
Sponsors & Collaborators
-
Istanbul Medipol University Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-10-15
- Primary Completion
- 2019-06-15
- Completion
- 2019-09-15
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Use of Ozone Gel as an Antimicrobial in Treatment of Periodontitis
NCT05905445 ·Status: COMPLETED ·Phase: PHASE1
-
The Role of Probiotics in Periodontal Disease
NCT05211219 ·Status: COMPLETED ·Phase: NA
-
The Influence of Local Antibiotic Therapy on the Outcomes Following Periodontal Regeneration Procedures.
NCT07027137 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effects of Smoking on Oral Tissue Samples
NCT05484765 ·Status: COMPLETED
-
Evaluation of Nutritional Habits, Oral Hygiene, Relationship Between Dental Caries and Periodontal Condition
NCT06129357 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of Biomarkers Levels in Gingival Crevicular Fluid, Saliva and Serum for Different Periodontal Diseases
NCT05435131 ·Status: COMPLETED ·Phase: NA
-
Alternative Antibiotic Regimen in Periodontitis Treatment
NCT04353362 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment the Efficacy of Curcumin Local Delivery Gel in Treatment of Periodontitis in Smokers
NCT06653231 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effects of Smoking on Clinical and Microbiological Response in Individuals With Periodontitis
NCT06383455 ·Status: COMPLETED
-
Impact of Non Surgical Periodontal Therapy on Cystatin C Levels
NCT07103421 ·Status: COMPLETED ·Phase: NA
-
The Effects of Periodontal Therapy on Glycemic Control in Diabetic Patients
NCT03783845 ·Status: COMPLETED ·Phase: PHASE4
-
EVALUATION OF SALIVARY BİOMARKER LEVELS IN SMOKING AND NON-SMOKER INDIVIDUALS WITH DIFFERENT PERIODONTAL DISEASES
NCT06971770 ·Status: COMPLETED ·Phase: NA
-
Analysis of the Impact of Contemporary Subgingival Debridement Techniques on Immunological Biomarkers in Gingival Crevicular Fluid
NCT07243145 ·Status: COMPLETED
-
Comparative Analysis of Gremlin-1, Syndecan-4 and IL-1 Beta Levels in Gingival Crevicular Fluid Among İndividuals With Periodontal Health and Stage III Periodontitis, Considering Both Smokers and Non-Smokers, Before and After Non-Surgical Periodontal Therapy
NCT06687005 ·Status: ACTIVE_NOT_RECRUITING
-
Photodynamic Therapy in Root Canal Treatment of T2DM Patients: Microbiome Analysis Via Next-Gen Sequencing
NCT06931678 ·Status: COMPLETED ·Phase: NA
-
Periodontal Pathogens and Atherom Plaque The Number of Mitochondrial DNA Copies
NCT07165054 ·Status: COMPLETED
-
Gut Microbial Changes After Periodontal Treatment
NCT04982302 ·Status: COMPLETED
-
Efficacy of Subgingivally Delivered Doxycycline Plus Ketoprofen Gel as an Adjunct to Non-surgical Periodontal Treatment
NCT02538224 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Effect of Smoking on Peri-implantitis
NCT06150066 ·Status: ACTIVE_NOT_RECRUITING
-
Effect of Aerosol From THS and Cigarette Smoke on Periodontal Tissues and Its Microbiome
NCT06480877 ·Status: COMPLETED
-
Measurement of Oncostatin M, Leukemia Inhibitory Factor and Interleukin-11 Levels of Patients With Periodontal Disease
NCT04597073 ·Status: COMPLETED ·Phase: NA
-
Menopause and Oral Microbiome
NCT05335733 ·Status: COMPLETED
-
Evaluation of Biomarker Levels in Blood, Saliva and Gingival Fluid in Periodontitis
NCT04647123 ·Status: UNKNOWN
-
Periodontal Status in Fermented Food and Food Consumption
NCT05602545 ·Status: COMPLETED ·Phase: NA
-
Chemerin, Fetuin-A, IL-34 and IL-13 Levels in Diabetic Periodontitis Patients
NCT06135532 ·Status: COMPLETED ·Phase: NA